Agenda I status surely enhances the volume of complexity for almost any investigate review. By way of example, all researchers—whether or not preclinical or clinical—ought to get hold of Plan I investigate registrations. 21 CFR part 1301.18. Against this, researchers which have DEA Practitioner registrations in Schedules II–V (which most doct